GO
Loading...

Merck & Co Inc

More

  • Some big U.S. companies dodge state income taxes -study Thursday, 20 Mar 2014 | 6:11 PM ET

    Among companies named in the study were aerospace group Boeing Co, drugmaker Merck& Co Inc and industrial group Rockwell Automation Inc.. Some states did not collect corporate taxes in the years CTJ examined, including Washington State, where Boeing was founded.

  • *Novartis reviewing fate of animal health, vaccines and OTC units. BASEL, Switzerland, March 20- Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new era in healthcare spending.

  • *MAGE-A3 fails to hit goal in Phase III lung cancer trial. March 20- An experimental cancer vaccine from GlaxoSmithKline has failed in a second test- this time against lung cancer- but the British company said it still hoped to identify a sub-group of patients in which it would work.

  • March 20- An experimental cancer vaccine from GlaxoSmithKline has failed in a second test- this time against lung cancer- but the British group said it still hoped to find a sub-group of patients in which it would work.

  • Cramer’s 5 portfolio building block stocks Tuesday, 18 Mar 2014 | 6:25 PM ET

    If you’re looking to build a portfolio of stocks, here’s how Cramer would put money to work right here and right now.

  • March 14- An experimental Amgen Inc cancer vaccine used to treat advanced melanoma, the deadliest form of skin cancer, proved effective in a late-stage study in shrinking tumors in a way that suggests the drug triggered the intended systemic immune response, according to data presented on Friday.

  • Your first trade for Friday Thursday, 13 Mar 2014 | 1:24 PM ET

    The "Fast Money" traders share their final trades of the day.

  • March 12- The number of U.S. cattle deaths that may be linked to the Merck& Co Inc feed additive Zilmax are much higher than the figures reported by the drug company to the federal government, according to a research study published on Wednesday.

  • Cramer: Build new portfolio with these 5 stocks Wednesday, 12 Mar 2014 | 6:43 PM ET

    If you’ve got $10,000 for investment, here’s how Cramer would put that money to work, right here and right now.

  • March 12- The number of U.S. cattle deaths that may be linked to the Merck& Co Inc feed additive Zilmax are much higher than the figures reported by the drug company to the federal government, according to a research study published on Wednesday.

  • March 10- Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36 percent.

  • March 10- German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy.

  • Several insurers, including Molina Healthcare, which administer health plans for California's Medicaid program for the poor are asking states to step in and pay for Gilead Sciences Inc's Sovaldi, a drug that costs $84,000 per patient.

  • Pharma offering new hope for hepatitis C patients Wednesday, 26 Feb 2014 | 1:21 PM ET
    Hepatitis C virus

    New pill treatments show better cure rates and fewer side effects. Here are the companies behind those therapies.

  • *Men's Wearhouse raises offer for Jos. Gains were broad, with nine of the 10 S&P 500 sectors up on the day and a number of bellwethers, including Caterpillar Inc and Merck& Co, hitting 52- week highs.

  • *Insurance stocks rise after Humana comments. *Men's Wearhouse raises offer for Jos. Gains were broad, with nine of the 10 S&P 500 sectors up on the day and a number of bellwethers, including Caterpillar Inc and Merck& Co, hitting 52- week highs.

  • Before you put your next dollar in stocks, Cramer would like a word about cyclical versus secular stocks.

  • After-hours buzz: Tesla, Facebook, Safeway & More Wednesday, 19 Feb 2014 | 4:47 PM ET

    Check out which companies are making headlines after the bell Wednesday.

  • NEW YORK/ LONDON, Feb 19- A handful of consumer and healthcare companies including Bayer AG and Novartis are exploring a deal for Merck& Co Inc's consumer healthcare business, as they seek to gain scale in a fragmented industry, according to several people familiar with the matter.

  • Trading a stock picker's market Tuesday, 18 Feb 2014 | 1:15 PM ET
    Traders on the floor of the New York Stock Exchange.

    With correlation levels back to where they were before the financial crisis, investors are embracing the stock picker's market.

Most Popular Video

Wednesday, 23 Apr 2014 | 4:57 PM ET

Weekly jobless claims and durable goods are the numbers to watch Thursday, but so are the massive amount of earnings reports expected. CNBC's Patti Domm explains.

Wednesday, 23 Apr 2014 | 4:32 PM ET

Apple is reporting Q2 EPS of $11.62 on revenue of $45.6 billion. Gene Munster, Piper Jaffray senior research analyst, says investors should feel a sense of relief on these numbers.

Wednesday, 23 Apr 2014 | 3:23 PM ET

CNBC's Becky Quick discusses Warren Buffett's feelings about the market.